1zi5: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
[[Image:1zi5.gif|left|200px]]
{{Seed}}
[[Image:1zi5.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1zi5|  PDB=1zi5  |  SCENE=  }}  
{{STRUCTURE_1zi5|  PDB=1zi5  |  SCENE=  }}  


'''Crystal Structure of Human N-acetylgalactosaminyltransferase (GTA) Complexed with H type I Trisaccharide'''
===Crystal Structure of Human N-acetylgalactosaminyltransferase (GTA) Complexed with H type I Trisaccharide===




==Overview==
<!--
The human ABO(H) blood group A and B antigens are generated by the homologous glycosyltransferases A (GTA) and B (GTB), which add the monosaccharides GalNAc and Gal, respectively, to the cell-surface H antigens. In the first comprehensive structural study of the recognition by a glycosyltransferase of a panel of substrates corresponding to acceptor fragments, 14 high resolution crystal structures of GTA and GTB have been determined in the presence of oligosaccharides corresponding to different segments of the type I (alpha-l-Fucp-(1--&gt;2)-beta-D-Galp-(1--&gt;3)-beta-D-GlcNAcp-OR, where R is a glycoprotein or glycolipid in natural acceptors) and type II (alpha-l-Fucp-(1--&gt;2)-beta-D-Galp-(1--&gt;4)-beta-d-GlcNAcp-OR) H antigen trisaccharides. GTA and GTB differ in only four "critical" amino acid residues (Arg/Gly-176, Gly/Ser-235, Leu/Met-266, and Gly/Ala-268). As these enzymes both utilize the H antigen acceptors, the four critical residues had been thought to be involved strictly in donor recognition; however, we now report that acceptor binding and subsequent transfer are significantly influenced by two of these residues: Gly/Ser-235 and Leu/Met-266. Furthermore, these structures show that acceptor recognition is dominated by the central Gal residue despite the fact that the L-Fuc residue is required for efficient catalysis and give direct insight into the design of model inhibitors for GTA and GTB.
The line below this paragraph, {{ABSTRACT_PUBMED_16326711}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16326711 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16326711}}


==Disease==
==Disease==
Line 39: Line 43:
[[Category: H-antigen]]
[[Category: H-antigen]]
[[Category: Retaining]]
[[Category: Retaining]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 17:39:14 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 16:17:17 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA